Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Opt Express ; 27(10): 14283-14297, 2019 May 13.
Article in English | MEDLINE | ID: mdl-31163879

ABSTRACT

The effects of ion clustering and excited state absorption occurring in holmium-doped fiber lasers are investigated experimentally and theoretically. It is found that the slope efficiencies of holmium-doped fiber lasers are reduced by inhomogeneous upconversion associated with the clustering of Ho3+ ions. Via theoretical analysis based upon Judd-Ofelt theory, it is also found that the effect of excited state absorption on the performance of Ho-doped fiber lasers is negligible, a fact indicating that ion clustering is the dominant cause of the lower-than-expected slope efficiencies observed in holmium-doped fiber lasers. We argue that ion clustering is an intrinsic flaw of holmium-doped fibers and is difficult to eliminate, because our research efforts are based on commercially available low-concentration fiber, which is fabricated with state-of-the-art techniques.

3.
Blood ; 120(15): 3089-97, 2012 Oct 11.
Article in English | MEDLINE | ID: mdl-22927245

ABSTRACT

The nucleoporin gene NUP98 is fused to several genes including HOXD13 in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia, and chronic myeloid leukemia, blast crisis. Genetically engineered mice that express a NUP98-HOXD13 (NHD13) transgene (Tg) display the phenotypic features of MDS, including cytopenias, bone marrow dysplasia, and transformation to acute leukemia. Here we show that short-term treatment with the p53 inhibitor Pifithrin-α partially and transiently rescued the myeloid and lymphoid abnormalities found in NHD13(+) Tg mice, with no improvement in the anemia, while the genetic deletion of 2 alleles of p53 rescued both the myeloid progenitor cell and long-term hematopoietic stem cell compartments. Nonetheless, loss of one or both alleles of p53 did not rescue the MDS phenotype, but instead exacerbated the MDS phenotype and accelerated the development of acute myeloid leukemia. Our studies suggest that while targeting p53 may transiently improve hematopoiesis in MDS, over the long-term, it has detrimental effects, raising caution about abrogating its function to treat the cytopenias that accompany this disease.


Subject(s)
Cell Transformation, Neoplastic/pathology , Disease Models, Animal , Leukemia, Myeloid, Acute/etiology , Myelodysplastic Syndromes/complications , Oncogene Proteins, Fusion/physiology , Tumor Suppressor Protein p53/physiology , Animals , Benzothiazoles/pharmacology , Female , Flow Cytometry , Haploinsufficiency , Hematopoietic Stem Cells/pathology , Humans , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/pathology , Survival Rate , Toluene/analogs & derivatives , Toluene/pharmacology , Tumor Suppressor Protein p53/antagonists & inhibitors
4.
Blood ; 120(8): 1601-12, 2012 Aug 23.
Article in English | MEDLINE | ID: mdl-22776820

ABSTRACT

We recently defined a critical role for p53 in regulating the quiescence of adult hematopoietic stem cells (HSCs) and identified necdin as a candidate p53 target gene. Necdin is a growth-suppressing protein and the gene encoding it is one of several that are deleted in patients with Prader-Willi syndrome. To define the intrinsic role of necdin in adult hematopoiesis, in the present study, we transplanted necdin-null fetal liver cells into lethally irradiated recipients. We show that necdin-null adult HSCs are less quiescent and more proliferative than normal HSCs, demonstrating the similar role of necdin and p53 in promoting HSC quiescence during steady-state conditions. However, wild-type recipients repopulated with necdin-null hematopoietic stem/progenitor cells show enhanced sensitivity to irradiation and chemotherapy, with increased p53-dependent apoptosis, myelosuppression, and mortality. Necdin controls the HSC response to genotoxic stress via both cell-cycle-dependent and cell-cycle-independent mechanisms, with the latter occurring in a Gas2L3-dependent manner. We conclude that necdin functions as a molecular switch in adult hematopoiesis, acting in a p53-like manner to promote HSC quiescence in the steady state, but suppressing p53-dependent apoptosis in response to genotoxic stress.


Subject(s)
DNA Damage , Hematopoiesis , Hematopoietic Stem Cells/cytology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Apoptosis , Cell Proliferation , Cells, Cultured , Drug Therapy , Gene Deletion , Genes, p53 , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Hematopoietic Stem Cells/radiation effects , Liver/cytology , Liver/embryology , Mice , Mice, Inbred C57BL
5.
J Cell Physiol ; 226(9): 2215-21, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21660944

ABSTRACT

The p53 tumor suppressor protein is a key transcription factor that regulates several signaling pathways involved in the cell's response to stress. Through stress-induced activation, p53 accumulates and triggers the expression of target genes that protect the genetic integrity of all cells including hematopoietic stem cells (HSCs). These protective mechanisms include cell-cycle arrest, DNA repair, induction of apoptosis, or initiation of senescence. In addition to its function under stress conditions, p53 has important functions during steady-state hematopoiesis, regulating HSC quiescence and self-renewal. In addition, it appears that p53 levels affect HSC competition for the hematopoietic niche, with the less p53 activated HSCs preferentially surviving. The specific genes and precise mechanisms underlying p53's effects on normal HSCs are slowly being clarified. p53 also plays an important role in leukemia stem cell (LSC) behavior, with p53 loss affecting drug resistance and disease progression. Pharmacologic activation of p53 function could overcome the adverse impact of p53 inactivation in LSCs. Thus, understanding the p53 regulatory mechanisms active in HSCs and LSCs may promote the development of new therapeutic strategies that could eliminate the population of largely quiescent LSCs.


Subject(s)
Cell Lineage , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Cellular Senescence , Humans , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Stress, Physiological
6.
Cancer Res ; 71(14): 4857-65, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21616937

ABSTRACT

The ATM kinase plays a critical role in initiating the DNA damage response that is triggered by genotoxic stresses capable of inducing DNA double-strand breaks. Here, we show that ELF4/MEF, a member of the ETS family of transcription factors, contributes to the persistence of γH2AX DNA damage foci and promotes the DNA damage response leading to the induction of apoptosis. Conversely, the absence of ELF4 promotes the faster repair of damaged DNA and more rapid disappearance of γH2AX foci in response to γ-irradiation, leading to a radio-resistant phenotype despite normal ATM phosphorylation. Following γ-irradiation, ATM phosphorylates ELF4, leading to its degradation; a mutant form of ELF4 that cannot be phosphorylated by ATM persists following γ-irradiation, delaying the resolution of γH2AX foci and triggering an excessive DNA damage response. Thus, although ELF4 promotes the phosphorylation of H2AX by ATM, its activity must be dampened by ATM-dependent phosphorylation and degradation to avoid an excessive DNA damage response.


Subject(s)
DNA Breaks, Double-Stranded , DNA-Binding Proteins/metabolism , Transcription Factors/metabolism , Animals , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/metabolism , DNA/genetics , DNA/metabolism , DNA/radiation effects , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , DNA-Binding Proteins/radiation effects , Enzyme Activation , Gamma Rays , HEK293 Cells , Histones/metabolism , Humans , Mice , Mice, Knockout , NIH 3T3 Cells , Phosphorylation/radiation effects , Protein Serine-Threonine Kinases/metabolism , Transcription Factors/deficiency , Transcription Factors/genetics , Transcription Factors/radiation effects , Tumor Suppressor Proteins/metabolism
7.
Structure ; 17(8): 1104-16, 2009 Aug 12.
Article in English | MEDLINE | ID: mdl-19679088

ABSTRACT

Bacterial pathogenesis involves social behavior including biofilm formation and swarming, processes that are regulated by the bacterially unique second messenger cyclic di-GMP (c-di-GMP). Diguanylate cyclases containing GGDEF and phosphodiesterases containing EAL domains have been identified as the enzymes controlling cellular c-di-GMP levels, yet less is known regarding signal transmission and the targets of c-di-GMP. FimX, a protein from Pseudomonas aeruginosa that governs twitching motility, belongs to a large subfamily containing both GGDEF and EAL domains. Biochemical and structural analyses reveals its function as a high-affinity receptor for c-di-GMP. A model for full-length FimX was generated combining solution scattering data and crystal structures of the degenerate GGDEF and EAL domains. Although FimX forms a dimer in solution via the N-terminal domains, a crystallographic EAL domain dimer suggests modes for the regulation of FimX by c-di-GMP binding. The results provide the structural basis for c-di-GMP sensing via degenerate phosphodiesterases.


Subject(s)
Bacterial Proteins/chemistry , Cyclic GMP/analogs & derivatives , Models, Molecular , Protein Structure, Tertiary , Receptors, Cell Surface/chemistry , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Binding Sites , Catalysis , Crystallization , Crystallography, X-Ray , Cyclic GMP/chemistry , Cyclic GMP/metabolism , Hydrophobic and Hydrophilic Interactions , Models, Biological , Molecular Sequence Data , Protein Binding , Protein Conformation , Protein Folding , Protein Multimerization , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/metabolism , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Sequence Homology, Amino Acid , Signal Transduction
8.
PLoS Biol ; 6(3): e67, 2008 Mar 25.
Article in English | MEDLINE | ID: mdl-18366254

ABSTRACT

Environmental signals that trigger bacterial pathogenesis and biofilm formation are mediated by changes in the level of cyclic dimeric guanosine monophosphate (c-di-GMP), a unique eubacterial second messenger. Tight regulation of cellular c-di-GMP concentration is governed by diguanylate cyclases and phosphodiesterases, which are responsible for its production and degradation, respectively. Here, we present the crystal structure of the diguanylate cyclase WspR, a conserved GGDEF domain-containing response regulator in Gram-negative bacteria, bound to c-di-GMP at an inhibitory site. Biochemical analyses revealed that feedback regulation involves the formation of at least three distinct oligomeric states. By switching from an active to a product-inhibited dimer via a tetrameric assembly, WspR utilizes a novel mechanism for modulation of its activity through oligomerization. Moreover, our data suggest that these enzymes can be activated by phosphodiesterases. Thus, in addition to the canonical pathways via phosphorylation of the regulatory domains, both product and enzyme concentration contribute to the coordination of c-di-GMP signaling. A structural comparison reveals resemblance of the oligomeric states to assemblies of GAF domains, widely used regulatory domains in signaling molecules conserved from archaea to mammals, suggesting a similar mechanism of regulation.


Subject(s)
Bacterial Proteins/metabolism , Phosphorus-Oxygen Lyases/metabolism , Pseudomonas aeruginosa/enzymology , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Binding Sites , Catalysis , Chromatography, Gel , Crystallography, X-Ray , Cyclic GMP/metabolism , Dimerization , Enzyme Activation , Enzyme Stability , Escherichia coli Proteins , Feedback, Physiological , Light , Models, Biological , Molecular Weight , Phosphorus-Oxygen Lyases/antagonists & inhibitors , Phosphorus-Oxygen Lyases/chemistry , Phosphorus-Oxygen Lyases/isolation & purification , Phosphorylation , Protein Structure, Quaternary , Protein Structure, Tertiary , Scattering, Radiation
9.
J Neurosci ; 26(33): 8512-6, 2006 Aug 16.
Article in English | MEDLINE | ID: mdl-16914676

ABSTRACT

When deprived of trophic factors, the majority of cultured motor neurons undergo nitric oxide-dependent apoptosis. However, for reasons that have remained unclear, 30-50% of the motor neurons survive for several days without trophic factors. Here we hypothesize that the resistance of this motor neuron subpopulation to trophic factor deprivation can be attributed to diminished nitric oxide production resulting from the activity of the arginine-degrading enzyme arginase. When incubated with nor-N(G)-hydroxy-nor-L-arginine (NOHA), the normally resistant trophic factor-deprived motor neurons showed a drop in survival rates, whereas trophic factor-treated neurons did not. NOHA-induced motor neuron death was inhibited by blocking nitric oxide synthesis and the scavenging of superoxide and peroxynitrite, suggesting that peroxynitrite mediates NOHA toxicity. When we transfected arginase 1 into motor neurons to see whether it alone could abrogate trophic factor deprivation-induced death, we found that its forced expression did indeed do so. The protection afforded by arginase 1 expression is reversed when cells are incubated with NOHA or with low concentrations of nitric oxide. These results reveal that arginase acts as a central regulator of trophic factor-deprived motor neuron survival by suppressing nitric oxide production and the consequent peroxynitrite toxicity. They also suggest that the resistance of motor neuron subpopulations to trophic factor deprivation may result from increased arginase activity.


Subject(s)
Apoptosis/physiology , Arginase/physiology , Growth Substances/deficiency , Motor Neurons/physiology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Animals , Arginase/antagonists & inhibitors , Arginase/genetics , Arginine/analogs & derivatives , Arginine/pharmacology , Brain-Derived Neurotrophic Factor/pharmacology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Enzyme Inhibitors/pharmacology , Motor Neurons/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Peroxynitrous Acid/antagonists & inhibitors , Peroxynitrous Acid/metabolism , Rats , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...